Pacific Biosciences (PACB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2016 | 03-2016 | 12-2015 | 09-2015 | 06-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 24,778 | 20,080 | 33,629 | 27,208 | 25,930 |
| Marketable Securities | 77,692 | 71,451 | 48,641 | 31,701 | 46,744 |
| Receivables | 10,427 | 8,009 | 5,245 | 4,164 | 3,950 |
| Inventories | 14,201 | 12,162 | 10,955 | 11,621 | 11,978 |
| TOTAL | $138,055 | $119,053 | $110,541 | $86,207 | $90,189 |
| Non-Current Assets | |||||
| PPE Net | 11,188 | 9,093 | 8,548 | 7,855 | 6,428 |
| Other Non-Current Assets | 12,128 | 12,029 | 12,018 | 5,715 | 153 |
| TOTAL | $23,316 | $21,122 | $20,566 | $13,570 | $6,581 |
| Total Assets | $161,371 | $140,175 | $131,107 | $99,777 | $96,770 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,395 | 4,734 | 4,749 | 6,097 | 5,818 |
| Accrued Expenses | 16,329 | 12,201 | 15,551 | 11,342 | 11,316 |
| Other current liabilities | 1,422 | 1,444 | 241 | 627 | 991 |
| TOTAL | $33,813 | $32,010 | $38,178 | $38,754 | $39,017 |
| Non-Current Liabilities | |||||
| Long Term Debt | 15,496 | 15,216 | 14,948 | 14,808 | 14,567 |
| Deferred Revenues | 10,667 | 13,631 | 17,637 | 20,688 | 20,892 |
| Other Non-Current Liabilities | 1,796 | 2,013 | 1,986 | 2,248 | 3,091 |
| TOTAL | $19,489 | $19,389 | $19,389 | $19,653 | $23,917 |
| Total Liabilities | $53,302 | $51,399 | $57,567 | $58,407 | $62,934 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 91,875 | 87,169 | 85,731 | 77,041 | 74,969 |
| Common Shares | 91 | 87 | 80 | 76 | 75 |
| Retained earnings | -751,020 | -732,521 | -713,169 | -711,760 | -713,581 |
| Other shareholders' equity | 52 | 41 | -7 | 6 | 12 |
| TOTAL | $108,069 | $88,776 | $73,540 | $41,370 | $33,836 |
| Total Liabilities And Equity | $161,371 | $140,175 | $131,107 | $99,777 | $96,770 |